578 related articles for article (PubMed ID: 17255776)
41. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.
Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P
BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612
[TBL] [Abstract][Full Text] [Related]
42. Noninvasive urothelial carcinoma of the bladder with glandular differentiation: report of 24 cases.
Miller JS; Epstein JI
Am J Surg Pathol; 2009 Aug; 33(8):1241-8. PubMed ID: 19440144
[TBL] [Abstract][Full Text] [Related]
43. Benign-appearing urothelial tissue fragments in noninstrumented voided urine specimens are associated with low rates of urothelial neoplasia.
Onur I; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2015 Mar; 123(3):180-5. PubMed ID: 25586552
[TBL] [Abstract][Full Text] [Related]
44. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
[TBL] [Abstract][Full Text] [Related]
45. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
[TBL] [Abstract][Full Text] [Related]
46. Urothelial carcinoma with abundant myxoid stroma.
Tavora F; Epstein JI
Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
[TBL] [Abstract][Full Text] [Related]
47. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of fibroblast growth factor receptor 3 and epidermal growth factor receptors, in association with Raf-1, in urothelial dysplasia and carcinoma in situ after the Chernobyl accident.
Romanenko AM; Morimura K; Kinoshita A; Wanibuchi H; Takahashi S; Zaparin WK; Vinnichenko WI; Vozianov AF; Fukushima S
Cancer Sci; 2006 Nov; 97(11):1168-74. PubMed ID: 16965395
[TBL] [Abstract][Full Text] [Related]
49. Poorly differentiated colorectal carcinoma with invasion restricted to lamina propria (intramucosal carcinoma): a follow-up study of 15 cases.
Lewin MR; Fenton H; Burkart AL; Sheridan T; Abu-Alfa AK; Montgomery EA
Am J Surg Pathol; 2007 Dec; 31(12):1882-6. PubMed ID: 18043043
[TBL] [Abstract][Full Text] [Related]
50. Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.
Maxwell JP; Wang C; Wiebe N; Yilmaz A; Trpkov K
Diagn Pathol; 2015 Mar; 10():3. PubMed ID: 25886613
[TBL] [Abstract][Full Text] [Related]
51. Pseudocarcinomatous epithelial hyperplasia in the bladder unassociated with prior irradiation or chemotherapy.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):92-7. PubMed ID: 18162775
[TBL] [Abstract][Full Text] [Related]
52. Urothelial papilloma of the bladder. Clinical and biologic implications.
Cheng L; Darson M; Cheville JC; Neumann RM; Zincke H; Nehra A; Bostwick DG
Cancer; 1999 Nov; 86(10):2098-101. PubMed ID: 10570437
[TBL] [Abstract][Full Text] [Related]
53. The origins of urothelial carcinoma.
Cheng L; Davidson DD; Maclennan GT; Williamson SR; Zhang S; Koch MO; Montironi R; Lopez-Beltran A
Expert Rev Anticancer Ther; 2010 Jun; 10(6):865-80. PubMed ID: 20553211
[TBL] [Abstract][Full Text] [Related]
54. Cystoscopic biopsy supernate. A new cytologic approach for diagnosing urothelial carcinoma in situ.
DeBellis CC; Schumann GB
Acta Cytol; 1986; 30(4):356-9. PubMed ID: 3526778
[TBL] [Abstract][Full Text] [Related]
55. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia.
Desai S; Lim SD; Jimenez RE; Chun T; Keane TE; McKenney JK; Zavala-Pompa A; Cohen C; Young RH; Amin MB
Mod Pathol; 2000 Dec; 13(12):1315-23. PubMed ID: 11144928
[TBL] [Abstract][Full Text] [Related]
56. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
[TBL] [Abstract][Full Text] [Related]
57. Papillary urothelial hyperplasia. A precursor to papillary neoplasms.
Taylor DC; Bhagavan BS; Larsen MP; Cox JA; Epstein JI
Am J Surg Pathol; 1996 Dec; 20(12):1481-8. PubMed ID: 8944041
[TBL] [Abstract][Full Text] [Related]
58. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.
Reis LO; Taheri D; Chaux A; Guner G; Mendoza Rodriguez MA; Bivalacqua TJ; Schoenberg MP; Epstein JI; Netto GJ
Hum Pathol; 2016 Jan; 47(1):20-5. PubMed ID: 26520419
[TBL] [Abstract][Full Text] [Related]
59. Noninvasive low-grade papillary urothelial carcinoma with degenerative nuclear atypia: a grading pitfall.
Matoso A; Parimi V; Epstein JI
Hum Pathol; 2021 Jul; 113():1-8. PubMed ID: 33887303
[TBL] [Abstract][Full Text] [Related]
60. A series of vascular tumors and tumorlike lesions of the bladder.
Tavora F; Montgomery E; Epstein JI
Am J Surg Pathol; 2008 Aug; 32(8):1213-9. PubMed ID: 18580491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
